Clarithromycin Dosage and Treatment Regimen for Adults
For adults, the standard clarithromycin dosage is 1 gram per day in two divided doses (500 mg twice daily) for 7-14 days, with the duration depending on the specific infection being treated. 1
Standard Dosing Guidelines
The FDA-approved dosing regimen for clarithromycin extended-release tablets in adults is:
- Acute bacterial exacerbation of chronic bronchitis: 1 gram once daily for 7 days 1
- Acute maxillary sinusitis: 1 gram once daily for 14 days 1
- Community-acquired pneumonia: 1 gram once daily for 7 days 1
For immediate-release formulations, the dosing is typically:
- 250-500 mg twice daily (total 500-1000 mg daily) for 7-14 days depending on the infection 2
Specific Infection Protocols
For Pertussis (Whooping Cough)
- 1 gram per day in two divided doses (500 mg twice daily) for 7 days 2
For H. pylori Eradication
- Part of standard triple therapy: 500 mg twice daily (with PPI + amoxicillin) for 14 days 3
- The 14-day regimen is superior to 7-day regimens, with cure rates of approximately 95% versus 86% in susceptible populations 2
For Nontuberculous Mycobacterial Infections
- For serious skin, soft tissue, and bone infections caused by M. abscessus: 1000 mg/day or azithromycin 250 mg/day combined with parenteral medications (amikacin, cefoxitin, or imipenem) 2
- For pulmonary disease: typically part of a multi-drug regimen for at least 4-6 months 2
Dosage Adjustments
Renal Impairment
- Severe renal impairment (CrCl <30 mL/min): Reduce dosage by 50% 1
- Moderate renal impairment (CrCl 30-60 mL/min) with concomitant atazanavir or ritonavir: Reduce dosage by 50% 1
- Severe renal impairment with concomitant atazanavir or ritonavir: Reduce dosage by 75% 1
Administration Guidelines
- Clarithromycin extended-release tablets should be taken with food 1
- Tablets should be swallowed whole; do not chew, break, or crush extended-release tablets 1
Important Precautions and Contraindications
Contraindications
- Hypersensitivity to clarithromycin or any macrolide antibiotic 1
- Concomitant use with cisapride, pimozide, lomitapide, lovastatin, simvastatin, ergot alkaloids, or lurasidone 1
- History of cholestatic jaundice/hepatic dysfunction with prior clarithromycin use 1
- Colchicine in patients with renal or hepatic impairment 1
Drug Interactions
- Clarithromycin inhibits the cytochrome P450 enzyme system (CYP3A), which can lead to increased concentrations of drugs metabolized by this pathway 2
- Significant interactions with astemizole, cisapride, pimazole, terfenadine, and many other medications 2
- Reduce clarithromycin dose by 50% when co-administered with atazanavir 1
Common Adverse Effects
- Gastrointestinal: epigastric distress, abdominal cramps, nausea, vomiting, diarrhea 2
- Less common: hypersensitivity reactions, hepatotoxicity 2
Antimicrobial Stewardship Considerations
- Clarithromycin resistance should be considered when selecting therapy, particularly for H. pylori infections 2
- When resistance to clarithromycin exceeds 15-20%, alternative regimens should be considered 2
- For H. pylori treatment, culture-guided therapy can increase eradication rates from 72% to 94% compared to empiric therapy 4
Special Populations
- Pregnancy: FDA Pregnancy Category C - use only when benefits outweigh risks 2
- Infants <1 month: Not recommended due to potential risk similar to erythromycin-associated infantile hypertrophic pyloric stenosis 2
- Elderly: No dosage adjustment needed for normal renal function, but increased risk of torsades de pointes 1
By following these evidence-based dosing guidelines and considering patient-specific factors, clarithromycin can be effectively and safely used to treat various bacterial infections in adults.